New Corona Vaccine Participants in Clinical Trials Died in Brazil October 22, 7:41
The Brazilian government announced on the 21st that one of the volunteers who participated in the clinical trial of the new coronavirus vaccine being developed by pharmaceutical giant AstraZeneca and others died this month.
The government has not shown a causal link to clinical trials, but AstraZeneca says "there is no concern about the continuation of the trial," and the government has indicated that it will allow the trial to continue.
Brazil's Health Regulatory Authority announced yesterday that one of its volunteers died this month in a clinical trial of a new coronavirus vaccine being jointly developed by British pharmaceutical giant AstraZeneca and the University of Oxford. Did.
According to local media, the person who died was a 28-year-old doctor from Rio de Janeiro, who had been participating as a subject since July, but died this month after being infected with the new coronavirus last month.
Brazilian officials have not disclosed a causal link between volunteer deaths and clinical trials, but AstraZeneca told NHK that it would not comment on individual cases, saying "a medical problem arose. In that case, regulators and others will evaluate it, but we have not reached a situation where there is concern about the continuation of the trial. "
The University of Oxford has also stated that there are no safety issues with clinical trials, and the Brazilian government has indicated that it will allow the trials to continue.
Brazil has been recruiting volunteers to participate in clinical trials since June, and more than 5,000 people have participated in trials such as AstraZeneca.